Startup | May 01, 2022
Genome Insight draws US $ 23 million in Series B Funding
Funds will be allocated to accelerate rapid production and high-end curation of whole genome sequences for its clinical application
Funds will be allocated to accelerate rapid production and high-end curation of whole genome sequences for its clinical application
Star Array's focus has been on the development of an automated (cassette-based) nucleic acid purification system coupled with its superfast nucleic acid amplification technology
Strive to empower public health with disinfection robotics solutions in post-pandemic era
Cedars-Sinai Medical Center Surgeon and Surgical Innovation Officer Dr. Jain joins the venture fund to bring clinical expertise to a portfolio of budding seed-stage healthcare companies
Researchers from the Tel Aviv University successfully engineer the world's first 3D human spinal cord tissue transplant
Company announced that it is accelerating its investment in its Leaps by Bayer impact investment unit with more than 1.3 billion euros funding until end of 2024
Approval is based on results of a multicenter, randomized, open-labeled and controlled IDE clinical study that demonstrated the superiority of Agili-C™ implant to the current surgical standard of care, debridement and microfracture in the knee joint
Arizona-based, leading medical devices company, Confluent Medical Technologies, will be establishing a pilot manufacturing facility in Hyderabad.
The collaboration leverages Insilico's end-to-end AI-driven Pharma.AI platform to discover novel small molecule drug candidates for multiple targets, along with EQRx's innovative business model to accelerate drug development and patient access to novel medicines at affordable prices
Blood contains a mixture of exosomes secreted from nearly all tissues and cells, and exosomes from other tissues can mask changes caused by disease, making it difficult to detect the presence of biomarkers that reflect disease
Subscribe To Our Newsletter & Stay Updated
